2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN), a systematic review

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          Multiple interventions have been developed aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia (FN) following chemotherapy for cancer. We evaluated their effect to reduce TTA and their impact on important clinical outcomes in a systematic review.

          Methods

          The search covered seven databases. Biases and quality of studies were assessed with the Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) tool. Interventions could be implemented in any setting and performed by any person included in the FN management. Absolute change of TTA was the primary outcome. Registration: PROSPERO (CRD42018092948).

          Results

          Six thousand two hundred ninety-six titles and abstracts were screened, 177 studies were retrieved and 30 studies were included. Risk of bias was moderate to serious in 28 studies and low in two studies. All but one study reported a reduction of TTA after the intervention. Various types of interventions were implemented; they most commonly aimed at professionals. Most of the studies made more than one single intervention.

          Conclusion

          This review may help centers to identify their specific sources of delay and barriers to change and to define what intervention may be the best to apply. This review supports the assertion that TTA can be considered a measure of quality of care, emphasizes the importance of education and training, and describes the very different interventions which have effectively reduced TTA.

          Electronic supplementary material

          The online version of this article (10.1007/s00520-019-05056-w) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

          Hospitalization for febrile neutropenia (FN) in cancer patients is associated with considerable morbidity, mortality, and cost. The study was undertaken to better define mortality, length of stay (LOS), cost, and risk factors associated with mortality and prolonged hospitalization in cancer patients with FN. The longitudinal discharge database derived from 115 US medical centers was used to study all adult cancer patients hospitalized with FN between 1995 and 2000, comprising a total of 41,779 patients. Primary outcomes included mortality, LOS, and cost per episode. Overall, in-hospital mortality was 9.5%. Patients without any major comorbidities had a 2.6% risk of mortality, whereas 1 major comorbidity was associated with a 10.3% and more than 1 major comorbidity with a > or = 21.4% risk of mortality, respectively. Mean (median) length of stay was 11.5 (6) days, and the mean (median) cost was $19,110 ($8,376) per episode of FN. Patients hospitalized for > or = 10 days (35% of all patients) accounted for 78% of overall cost. Independent major risk factors for inpatient mortality included invasive fungal infections, Gram-negative sepsis, pneumonia and other lung disease, cerebrovascular, renal, and liver disease. Main predictors for LOS > or = 10 days included leukemia, invasive fungal infections, other types of infection, and several comorbid conditions. Factors associated with increased mortality, LOS, and cost in hospitalized adult cancer patients with FN include patient characteristics, type of malignancy, comorbidities, and infectious complications. These factors may be useful in identifying patients at increased risk of serious medical complications and mortality for more aggressive supportive care measures. Copyright 2006 American Cancer Society
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

                Bookmark

                Author and article information

                Contributors
                christa.koenig@insel.ch
                Journal
                Support Care Cancer
                Support Care Cancer
                Supportive Care in Cancer
                Springer Berlin Heidelberg (Berlin/Heidelberg )
                0941-4355
                1433-7339
                5 September 2019
                5 September 2019
                2020
                : 28
                : 5
                : 2369-2380
                Affiliations
                [1 ]GRID grid.5734.5, ISNI 0000 0001 0726 5157, Division of Pediatric Hematology/Oncology, Department of Pediatrics, Inselspital, Bern University Hospital, , University of Bern, ; Freiburgstrasse 15, CH-3010 Bern, Switzerland
                [2 ]GRID grid.5685.e, ISNI 0000 0004 1936 9668, Centre for Reviews and Dissemination, , University of York, ; York, UK
                [3 ]Leeds Children’s Hospital, Leeds, UK
                [4 ]GRID grid.17063.33, ISNI 0000 0001 2157 2938, The Hospital for Sick Children, , University of Toronto, ; Toronto, Ontario Canada
                Author information
                https://orcid.org/0000-0002-9965-5183
                https://orcid.org/0000-0001-8087-8638
                https://orcid.org/0000-0002-1902-2352
                https://orcid.org/0000-0003-0951-3091
                https://orcid.org/0000-0002-4938-9673
                Article
                5056
                10.1007/s00520-019-05056-w
                7083808
                31486984
                3c29c28d-69c0-44d3-826a-998f23a003d2
                © The Author(s) 2019

                Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 11 June 2019
                : 22 August 2019
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100004361, Krebsliga Schweiz;
                Award ID: KFS-3645-02-2015
                Award Recipient :
                Funded by: NIHR Post-Doctoral Fellowship
                Funded by: NIHR Clinical Lecturer Award
                Categories
                Original Article
                Custom metadata
                © Springer-Verlag GmbH Germany, part of Springer Nature 2020

                Oncology & Radiotherapy
                oncology,cancer,fever,neutropenia,time to antibiotics,quality improvement projects,systematic review

                Comments

                Comment on this article